![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PubMed:25163405 / 305-571
Annnotations
PubMed_Structured_Abstracts
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 0-266 | OBJECTIVE | denotes | To show the superiority of epinastine 0.05% ophthalmic solution (epinastine) to placebo ophthalmic solution (placebo) and noninferiority to olopatadine 0.1% ophthalmic solution (olopatadine) for cedar pollen antigen-induced ocular itching and conjunctival hyperemia. |
maxiaofeng52_800_3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 27-37 | CI | denotes | epinastine |
T9 | 65-75 | CI | denotes | epinastine |
T14 | 80-87 | CI | denotes | placebo |
T15 | 109-116 | CI | denotes | placebo |
T19 | 140-151 | CI | denotes | olopatadine |
T20 | 178-189 | CI | denotes | olopatadine |
wangzhuo19_800_3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T12 | 65-75 | CI | denotes | epinastine |
T14 | 27-37 | CI | denotes | epinastine |
T7 | 80-87 | CI | denotes | placebo |
T8 | 109-116 | CI | denotes | placebo |
T25 | 140-151 | CI | denotes | olopatadine |
T26 | 178-189 | CI | denotes | olopatadine |